Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention; a meta-analysis of randomized controlled trials

被引：0
|
作者：
Rodriguez, Z. [1 ]
Valdecanas, A. [1 ]
Palileo, N. [1 ]
机构：
[1] St Lukes Med Ctr Quezon City, Quezon City, Philippines
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1465 / 1465
页数：1
相关论文
共 50 条
  • [11] Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Khan, Muhammad Shahzeb
    Memon, Muhammad Mustafa
    Usman, Muhammad Shariq
    Alnaimat, Saed
    Khan, Safi U.
    Khan, Abdur Rahman
    Yamani, Naser
    Fugar, Setri
    Mookadam, Farouk
    Krasuski, Richard A.
    Doukky, Rami
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (05) : 465 - 476
  • [12] Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention
    Coughlan, J. J.
    Aytekin, Alp
    Ndrepepa, Gjin
    Schuepke, Stefanie
    Bernlochner, Isabell
    Mayer, Katharina
    Neumann, Franz Josef
    Menichelli, Maurizio
    Richardt, Gert
    Woehrle, Jochen
    Witzenbichler, Bernhard
    Gewalt, Senta
    Xhepa, Erion
    Kufner, Sebastian
    Sager, Hendrik B.
    Joner, Michael
    Ibrahim, Tareq
    Fusaro, Massimiliano
    Laugwitz, Karl Ludwig
    Schunkert, Heribert
    Kastrati, Adnan
    Cassese, Salvatore
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (07) : E010565
  • [13] Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Analysis from the Acute Coronary Syndrome Israeli Survey
    Eliaz, Ran
    Mengesha, Bethlehem
    Ovdat, Tal
    Iakobishvili, Zaza
    Hasdai, David
    Kheifets, Mark
    Klempfner, Robert
    Beigel, Roy
    Kalmanovich, Eran
    Alcalai, Ronny
    Levi, Amos
    [J]. CARDIOLOGY, 2022, 147 (02) : 113 - 120
  • [14] Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials
    Li, Weijun
    He, Wenhua
    Zhou, Yuqing
    Guo, Yanfei
    [J]. PLOS ONE, 2020, 15 (07):
  • [15] Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Zhang, Zeyi
    Chen, Ou
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (05) : 536 - 543
  • [16] Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?
    Giri, Jay
    Nathan, Ashwin
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) : 1587 - 1589
  • [17] De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials
    Abdelazeem, Basel
    Shehata, Joseph
    Abbas, Kirellos Said
    El-Shahat, Nahla Ahmed
    Baral, Nischit
    Adhikari, Govinda
    Khan, Hafiz
    Hassan, Mustafa
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 287 - 298
  • [18] Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials
    Li, Jingyuan
    Wang, Qian
    Wu, Chunliu
    Qu, Xiaoyu
    Zhang, Lei
    He, Xiaofeng
    Ma, Sicong
    Qiu, Miaohan
    Wang, Xiaozeng
    [J]. CARDIOLOGY, 2023, 148 (04) : 363 - 373
  • [19] De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials
    Basel Abdelazeem
    Joseph Shehata
    Kirellos Said Abbas
    Nahla Ahmed El-Shahat
    Nischit Baral
    Govinda Adhikari
    Hafiz Khan
    Mustafa Hassan
    [J]. American Journal of Cardiovascular Drugs, 2022, 22 : 287 - 298
  • [20] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Deepak L. Bhatt
    [J]. Current Atherosclerosis Reports, 2008, 10 (5) : 367 - 368
12345